Reuters logo
BRIEF-Kite Pharma reports Q1 non-GAAP loss per share of $1.28
May 8, 2017 / 12:21 PM / 7 months ago

BRIEF-Kite Pharma reports Q1 non-GAAP loss per share of $1.28

May 8 (Reuters) - Kite Pharma Inc

* Kite reports first quarter financial results

* Q1 non-GAAP loss per share $1.28 excluding items

* Q1 loss per share $1.74

* Q1 revenue $9.8 million

* Q1 revenue view $12.3 million -- Thomson Reuters I/B/E/S

* Q1 earnings per share view $-1.71 -- Thomson Reuters I/B/E/S

* Continues to expect full year 2017 net cash burn to be between $325 million and $340 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below